APOG vs CVLG

APOG exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet stability. While the current price of $38.29 is slightly above the Graham Number ($31.86), it trades at a significant discount to its growth-based intrinsic value of $55.17 and a very attractive forward P/E of 10.73. Despite stagnant revenue growth and a bearish technical trend, the company's consistent track record of earnings beats and conservative debt-to-equity ratio (0.56) provide a strong margin of safety. The combination of deep value and high deterministic health makes this a compelling long-term play.

CVLG exhibits a severe disconnect between its current market price ($34.07) and its deterministic value, with a Piotroski F-Score of 4/9 indicating only stable health and a Graham Number of $7.62 suggesting significant overvaluation. While the stock has shown strong recent price momentum, the fundamentals are deteriorating, evidenced by a -29.2% YoY earnings decline and an unsustainable dividend payout ratio of 175%. The massive gap between the current P/E (212.94) and the Forward P/E (13.07) indicates the market is pricing in an aggressive earnings recovery that is not yet supported by current data. Heavy insider selling by the CEO and CFO further reinforces a bearish outlook.